ILC3s regulate the gut microbiota via host intestinal galactosylation to limit pathogen infection in mice

Ducarmon, Q. R. et al. Gut microbiota and colonization resistance against bacterial enteric infection. Microbiol. Mol. Biol. Rev. 83, e00007-19 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Guo, X. et al. Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity 40, 25–39 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang, J. et al. Group 3 innate lymphoid cells protect the host from the uropathogenic Escherichia coli infection in the bladder. Adv. Sci. 9, e2103303 (2022).

Article  Google Scholar 

Klose, C. S. & Artis, D. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat. Immunol. 17, 765–774 (2016).

Article  CAS  PubMed  Google Scholar 

Collins, J. W. et al. Citrobacter rodentium: infection, inflammation and the microbiota. Nat. Rev. Microbiol. 12, 612–623 (2014).

Article  CAS  PubMed  Google Scholar 

Guo, X. et al. Innate lymphoid cells control early colonization resistance against intestinal pathogens through ID2-dependent regulation of the microbiota. Immunity 42, 731–743 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

He, Y. et al. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity. Cell. Metab. 33, 988–1000.e7 (2021).

Article  CAS  PubMed  Google Scholar 

Ferreyra, J. A. et al. Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance. Cell Host Microbe 16, 770–777 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goto, Y., Uematsu, S. & Kiyono, H. Epithelial glycosylation in gut homeostasis and inflammation. Nat. Immunol. 17, 1244–1251 (2016).

Article  CAS  PubMed  Google Scholar 

Bennett, E. P. et al. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology 22, 736–756 (2012).

Article  CAS  PubMed  Google Scholar 

Hansson, G. C. Mucins and the microbiome. Annu. Rev. Biochem. 89, 769–793 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goto, Y. et al. Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 345, 1254009 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Pham, T. A. et al. Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen. Cell Host Microbe 16, 504–516 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao, S. et al. Core fucosylation of intestinal epithelial cells protects against Salmonella Typhi infection via up-regulating the biological antagonism of intestinal microbiota. Front. Microbiol. 11, 1097 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Yao, Y. et al. Mucus sialylation determines intestinal host-commensal homeostasis. Cell 185, 1172–1188.e28 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agarwal, K. et al. Resident microbes shape the vaginal epithelial glycan landscape. Sci. Transl. Med. 15, eabp9599 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eberl, G. & Littman, D. R. Thymic origin of intestinal αβ T cells revealed by fate mapping of RORγt+ cells. Science 305, 248–251 (2004).

Article  CAS  PubMed  Google Scholar 

Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91–97 (2018).

Article  CAS  PubMed  Google Scholar 

Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066–9071 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buffie, C. G. & Pamer, E. G. Microbiota-mediated colonization resistance against intestinal pathogens. Nat. Rev. Immunol. 13, 790–801 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kamada, N. et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336, 1325–1329 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rooks, M. G. & Garrett, W. S. Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16, 341–352 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smith, M. A., Mendz, G. L., Jorgensen, M. A. & Hazell, S. L. Fumarate metabolism and the microaerophily of Campylobacter species. Int. J. Biochem. Cell Biol. 31, 961–975 (1999).

Article  CAS  PubMed  Google Scholar 

Rosenberg, G. et al. Host succinate is an activation signal for Salmonella virulence during intracellular infection. Science 371, 400–405 (2021).

Article  CAS  PubMed  Google Scholar 

Guo, X. K., Ou, J., Liang, S., Zhou, X. & Hu, X. Epithelial Hes1 maintains gut homeostasis by preventing microbial dysbiosis. Mucosal Immunol. 11, 716–726 (2018).

Article  CAS  PubMed  Google Scholar 

Derrien, M., Vaughan, E. E., Plugge, C. M. & de Vos, W. M. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 54, 1469–1476 (2004).

Article  CAS  PubMed  Google Scholar 

Luis, A. S. & Hansson, G. C. Intestinal mucus and their glycans: a habitat for thriving microbiota. Cell Host Microbe 31, 1087–1100 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kosciow, K. & Deppenmeier, U. Characterization of three novel β-galactosidases from Akkermansia muciniphila involved in mucin degradation. Int. J. Biol. Macromol. 149, 331–340 (2020).

Article  CAS  PubMed  Google Scholar 

Ottman, N. et al. Genome-scale model and omics analysis of metabolic capacities of Akkermansia muciniphila reveal a preferential mucin-degrading lifestyle. Appl. Environ. Microbiol. 83, e01014-17 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Tran, D. T. & Ten Hagen, K. G. Mucin-type O-glycosylation during development. J. Biol. Chem. 288, 6921–6929 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin, M. C. et al. C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer. Oncogene 37, 5780–5793 (2018).

Comments (0)

No login
gif